Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Heart Rate Control as an Additional Therapeutic Strategy in Patients With Decompensated Heart Failure: a Prospective, Randomized, Double-blinded, Placebo-controlled Study.

Trial Profile

Heart Rate Control as an Additional Therapeutic Strategy in Patients With Decompensated Heart Failure: a Prospective, Randomized, Double-blinded, Placebo-controlled Study.

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 07 Dec 2018

At a glance

  • Drugs Ivabradine (Primary)
  • Indications Decompensated heart failure
  • Focus Therapeutic Use
  • Acronyms CONSTATHE
  • Most Recent Events

    • 01 Nov 2016 Planned End Date changed from 1 Nov 2015 to 1 Aug 2017.
    • 01 Nov 2016 Planned primary completion date changed from 1 May 2015 to 1 Jan 2017.
    • 18 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top